Publications by authors named "Chiara Zani"
Article Synopsis
- Glioblastoma (GBM) is a highly aggressive brain tumor with a poor prognosis, typically treated with surgery followed by radiotherapy and temozolomide; a trial is assessing the addition of Dendritic Cell vaccination (DCvax) to standard therapy.* ! -
- The study is a phase II trial involving 9 patients, focusing on progression-free survival (PFS) and safety, with DCvax administered after standard treatment and showing promising early immune response results.* ! -
- Initial findings indicate that the combination therapy is well-tolerated and achieves the initial study endpoints, allowing enrollment of additional patients to continue the research.* !
Investigational drug services need to be organised in a structured approach, especially for sites with a large number of ongoing clinical trials. The aim of this study was to develop a tool to assess the complexity of pharmacy involvement in a sponsored oncology clinical trial. Categorisation into ordinal complexity categories was used to assess the complexity of the clinical trials for consistent pharmacy grant applications.
View Article and Find Full Text PDFIstituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS is a public-private partnership among 3 public sector bodies and 6 private nonprofit organizations and represents the hub of the Oncology Network of Romagna, which provides a wide range of services for the population ranging from primary prevention to palliative care. In 2012, IRST took part in the ministerial research project of the Organisation of European Cancer Institutes (OECI) accreditation program for Comprehensive Cancer Centers. The self-assessment period lasted 6 months and was coordinated by a multidisciplinary project team headed by a project leader.
View Article and Find Full Text PDF